Abstract
Background
Objective
Design
Results
Conclusions
Key Words
Level of Evidence
Recommendations
Background
Gene Involved | Effect on Müllerian Duct | ||
---|---|---|---|
Partially Abnormal | Rudimentary Structure | Absence of Vagina or Uterus | |
Dach 1 | ✓ | ✓ | |
Dach 2 | ✓ | ✓ | |
Dlg 1 | ✓ | ✓ | |
Emx 2 | ✓ | ||
Lamc 1 | ✓ | ||
Lhx 1 | ✓ | ✓ | |
Pax 2 | ✓ | ✓ | |
Pax 8 | ✓ | ✓ | |
Rar a | ✓ | ✓ | |
Rar b | ✓ | ✓ | |
Wnt 4 | ✓ | ||
Wnt 7a | ✓ | ||
Wnt 9b | ✓ | ✓ | ✓ |
Development of the Reproductive Tract
Gestational Age (weeks) | Developmental Stage |
---|---|
6 | External and internal genital structures begin to form and common müllerian and wolffian systems exist |
9 | Urogenital sinus develops and lack of exposure to androgens allows regression of wolffian ducts and further development of müllerian ducts |
12-14 | Müllerian ducts fuse with urogenital sinus |
15-26 | Cephalic growth of sinovaginal bulb occurs |
15-26 | After cephalic growth occurs, fusion of sinovaginal bulb will help form the vaginal plate. Subsequently, canalization of the vagina occurs. |
Class | Müllerian Structure Type |
---|---|
I | Agenesis, dysgenesis, or atresia |
II | Unicornuate uterus with or without communicating or non-communicating horn associated |
III | Didelphic uterus |
IV | Bicornuate uterus or arcuate uterus |
V | Septate uterus (partial or complete) |
VI | DES-exposed |
Class | Subclass | Müllerian Structure Type |
---|---|---|
1 | 1.1, 1.2 | Rokitansky with unilateral renal agenesis or unicornuate with unilateral renal agenesis |
2 | 2.1, 2.2, 2.3, 2.4, 2.5 | Didelphic, bicornuate, or unicornuate uterus with ipsilateral or unilateral renal agenesis |
3 | 3A1, 3A2, 3A3, 3A4, 3A5, 3A6, 3A7, 3B1, 3B2, 3C | Müllerian agenesis, didelphic uterus, bicornuate uterus, unicornuate uterus, arcuate, septate, DES uterus without renal anomaly with or without complete or segmental atresias |
4 | None | Accessory uterine masses with other gubernaculum dysfunction |
5 | None | Anomalies of the urogenital sinus |
6 | None | Malformative combinations |
Clinical Presentation and Diagnosis of the Obstructive Anomaly
Primary Amenorrhea due to an Obstructed Anomaly




Severe Dysmenorrhea in the Presence of Menstrual Cycles due to an Obstructive Müllerian Anomaly
Diagnostic Testing
Treatment
Medical Treatment
Surgical Treatment
Imperforate Hymen
Transverse Vaginal Septum
Cervical Dysgenesis and Cervico-vaginal Agenesis
Obstructed Hemivagina Including OHVIRA
Communicating or Noncommunicating Uterine Horns
Lower Vagina Atresia
Conclusion
Appendix
- Studies were reviewed and evaluated for quality according to the method outlined by the U.S. Preventive Services Task Force:
- I.Evidence obtained from at least 1 properly designed randomized controlled trial.
- II-1.Evidence obtained from well-designed controlled trials without randomization.
- II-2.Evidence obtained from well-designed cohort or case-control analytic studies, preferably from more than 1 center or research group.
- II-3.Evidence obtained from multiple time series with or without the intervention. Dramatic results in uncontrolled experiments also could be regarded as this type of evidence.
- III.Opinions of respected authorities, based on clinical experience, descriptive studies, or reports of expert committees.
- I.
- Based on the highest level of evidence found in the data, recommendations are provided and graded according to the following categories:
- Level A—Recommendations are based on good and consistent scientific evidence.
- Level B—Recommendations are based on limited or inconsistent scientific evidence.
- Level C—Recommendations are based primarily on consensus and expert opinion.
References
- Mullerian anomalies.Obstet Gynecol Clin North Am. 2009; 36: 47
- Genetics of the female reproductive ducts.Am J Med Genet. 1999; 89: 224
- Identification and functional analysis of a new WNT4 gene mutation among 28 adolescent girls with primary amenorrhea and mullerian duct abnormalities: a French collaborative study.J Clin Endocrinol Metab. 2008; 93: 895
- Genetic basis for the development of mullerian abnormalities: a review of current evidence.Eur J Obstet Gynecol. 2010; 5: 7
- The role of genes in the development of Mullerian anomalies: where are we today?.Obstet Gynecol Surv. 2009; 64: 760
- Müllerian anomalies: a proposed classification. (An analysis of 144 cases).Fertil Steril. 1979; 32: 40
- The history of female genital tract malformation classifications and proposal of an updated system.Hum Reprod Update. 2011; 17: 693
Laufer MR: Structural abnormalities of the female reproductive tract. In: Emans, Laufer, Goldstein's Pediatric and Adolescent Gynecology, 6th ed. Edited by Emans SJ, Laufer MR. 2012, p 334.
- Obstructive anomalies of the female reproductive tract.J Reprod Med. 1999; 44: 233
- ACOG Committee Opinion No. 349, November 2006: Menstruation in girls and adolescents: using the menstrual cycle as a vital sign.Obstet Gynecol. 2006; 108: 1323
- Mullerian duct anomalies: MR imaging.Abdom Imaging. 2011; 36: 756
- Congenital anomalies of the müllerian system.Fertil Steril. 1989; 51: 747
- The utility of ultrasound and magnetic resonance imaging versus surgery for the characterization of mullerian anomalies in the pediatric and adolescent population.J Pediatr Adolesc Gynecol. 2012; 25: 181
- Anomalous development of the vagina.Semin Reprod Endocrinol. 1986; 4: 13
- Adolescent dysmenorrhea.Endocr Dev. 2012; 22: 171
- Obstructed hemivagina and ipsilateral renal anomaly (OHVIRA) syndrome: management and follow-up.Fertil Steril. 2007; 87: 918
- Herlyn-Werner-Wunderlich Syndrome: a rare presentation with pyocolpos.J Radiol Case Rep. 2012; 6: 9
- Prepubertal presentation of Herlyn-Werner-Wunderlich syndrome: a case report.J Pediatr Surg. 2011; 46: 1277
- Obstructed hemivagina and ipsilateral renal agenesis (OHVIRA) syndrome with a single uterus.Fertil Steril. 2011; 96: e39-e41
- The presentation and early diagnosis of the rudimentary uterine horn.Obstet Gynecol. 2005; 105: 1456
- Müllerian duct anomalies and mimics in children and adolescents: correlative intraoperative assessment with clinical imaging.Radiographics. 2009; 29: 1085
- Diagnosis of uterine anomalies: relative accuracy of MR imaging, endovaginal sonography, and hysterosalpingography.Radiology. 1992; 183: 795
- Surgical correction of vaginal anomalies.Clin Obstet Gynecol. 2008; 51: 223
- Clinical implications of the didelphic uterus: long-term follow-up of 49 cases.Eur J Obstet Gynecol Reprod Biol. 2000; 91: 183
- Diagnostic imaging modalities for müllerian anomalies: the case for a new gold standard.J Minim Invasive Gynecol. 2014; 21: 335
- Reproductive performance of women with mullerian anomalies.Curr Opin Obstet Gynecol. 2007; 19: 229
- The uterus and fertility.Fertil Steril. 2008; 89: 1
- Müllerian duct anomalies: review of current management.Sao Paulo Med J. 2009; 127: 92
- Hydrometrocolpos in neonate due to distal vaginal atresia.J Pediatr Surg. 1984; 19: 510
- Management of lower vaginal atresia in patient with a unicornuate uterus.J Pediatr Adolesc Gynecol. 2013; 26: e21
- Persistence of endometriosis after correction of an obstructed reproductive tract anomaly.J Pediatr Adolesc Gynecol. 2013; 26: e93
- Adolescent endometriosis: diagnosis and treatment approaches.J Pediatr Adolesc Gynecol. 2003; 16: S3
- Endometriosis and the adolescent.Clin Obstet Gynecol. 2010; 53: 420
- Endometriosis in association with uterine anomaly.Am J Obstet Gynecol. 1986; 154: 39
Article info
Publication history
Footnotes
This Clinical Recommendation has been prepared under the direction of the NASPAG Education Committee, and reviewed by the NASPAG Executive Committee and JPAG Editors
Committee Opinion NASPAG 2014
The authors indicate no conflicts of interest.
The authors would like to thank Marc Laufer, MD, for conducting the expert review for this document.
The information contained in this Clinical Recommendation reflects the currently available best evidence for practice at the time of publication. The information is designed to aid practitioners in making decisions about appropriate patient care, but should not be construed as dictating an exclusive course of treatment or procedure. Variations in practice may be warranted based on the needs of the individual patient, resources, and limitations unique to the institution or type of practice. This information has been reviewed and approved by NASPAG.